NF-κB is required for TNF-α-directed smooth muscle cell migration

Zhongbiao Wang, Manuel R Castresana, Walter H. Newman

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Migration of vascular smooth muscle cells (VSMC) is a crucial event in the formation of vascular stenotic lesions. Tumor necrosis factor-α (TNF-α) is elaborated by VSMC in atherosclerosis and following angioplasty. We investigated the role of nuclear factor-κB (NF-κB) in human VSMC migration induced by TNF-α. Adenoviral expression of a mutant form of the inhibitor of NF-κB, IκB-αM, suppressed TNF-α-triggered degradation of cellular IκB-α, inhibited activation of NF-κB, and attenuated TNF-α-induced migration. Further, IκB-αM suppressed TNF-α-stimulated release of interleukin-6 and -8 (IL-6 and IL-8). Neutralization of IL-6 and IL-8 with appropriate antibodies reduced TNF-α-induced VSMC migration. Addition of recombinant IL-6 and IL-8 stimulated migration. Collectively, our data provide initial evidence that TNF-α-mediated VSMC migration requires NF-κB activation and is associated with induction of IL-6 and IL-8 which act in an autocrine manner.

Original languageEnglish (US)
Pages (from-to)360-364
Number of pages5
JournalFEBS Letters
Volume508
Issue number3
DOIs
StatePublished - Nov 23 2001
Externally publishedYes

Fingerprint

Smooth Muscle Myocytes
Cell Movement
Muscle
Tumor Necrosis Factor-alpha
Cells
Interleukin-8
Vascular Smooth Muscle
Interleukin-6
Chemical activation
Angioplasty
Blood Vessels
Atherosclerosis
Degradation
Antibodies

Keywords

  • Interleukin-6
  • Interleukin-8
  • Migration
  • Nuclear factor κB
  • Smooth muscle cell
  • Tumor necrosis factor-α

ASJC Scopus subject areas

  • Structural Biology
  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

NF-κB is required for TNF-α-directed smooth muscle cell migration. / Wang, Zhongbiao; Castresana, Manuel R; Newman, Walter H.

In: FEBS Letters, Vol. 508, No. 3, 23.11.2001, p. 360-364.

Research output: Contribution to journalArticle

Wang, Zhongbiao ; Castresana, Manuel R ; Newman, Walter H. / NF-κB is required for TNF-α-directed smooth muscle cell migration. In: FEBS Letters. 2001 ; Vol. 508, No. 3. pp. 360-364.
@article{cd9fe7bf515c4598a0de4ed5c01f32f3,
title = "NF-κB is required for TNF-α-directed smooth muscle cell migration",
abstract = "Migration of vascular smooth muscle cells (VSMC) is a crucial event in the formation of vascular stenotic lesions. Tumor necrosis factor-α (TNF-α) is elaborated by VSMC in atherosclerosis and following angioplasty. We investigated the role of nuclear factor-κB (NF-κB) in human VSMC migration induced by TNF-α. Adenoviral expression of a mutant form of the inhibitor of NF-κB, IκB-αM, suppressed TNF-α-triggered degradation of cellular IκB-α, inhibited activation of NF-κB, and attenuated TNF-α-induced migration. Further, IκB-αM suppressed TNF-α-stimulated release of interleukin-6 and -8 (IL-6 and IL-8). Neutralization of IL-6 and IL-8 with appropriate antibodies reduced TNF-α-induced VSMC migration. Addition of recombinant IL-6 and IL-8 stimulated migration. Collectively, our data provide initial evidence that TNF-α-mediated VSMC migration requires NF-κB activation and is associated with induction of IL-6 and IL-8 which act in an autocrine manner.",
keywords = "Interleukin-6, Interleukin-8, Migration, Nuclear factor κB, Smooth muscle cell, Tumor necrosis factor-α",
author = "Zhongbiao Wang and Castresana, {Manuel R} and Newman, {Walter H.}",
year = "2001",
month = "11",
day = "23",
doi = "10.1016/S0014-5793(01)03109-X",
language = "English (US)",
volume = "508",
pages = "360--364",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - NF-κB is required for TNF-α-directed smooth muscle cell migration

AU - Wang, Zhongbiao

AU - Castresana, Manuel R

AU - Newman, Walter H.

PY - 2001/11/23

Y1 - 2001/11/23

N2 - Migration of vascular smooth muscle cells (VSMC) is a crucial event in the formation of vascular stenotic lesions. Tumor necrosis factor-α (TNF-α) is elaborated by VSMC in atherosclerosis and following angioplasty. We investigated the role of nuclear factor-κB (NF-κB) in human VSMC migration induced by TNF-α. Adenoviral expression of a mutant form of the inhibitor of NF-κB, IκB-αM, suppressed TNF-α-triggered degradation of cellular IκB-α, inhibited activation of NF-κB, and attenuated TNF-α-induced migration. Further, IκB-αM suppressed TNF-α-stimulated release of interleukin-6 and -8 (IL-6 and IL-8). Neutralization of IL-6 and IL-8 with appropriate antibodies reduced TNF-α-induced VSMC migration. Addition of recombinant IL-6 and IL-8 stimulated migration. Collectively, our data provide initial evidence that TNF-α-mediated VSMC migration requires NF-κB activation and is associated with induction of IL-6 and IL-8 which act in an autocrine manner.

AB - Migration of vascular smooth muscle cells (VSMC) is a crucial event in the formation of vascular stenotic lesions. Tumor necrosis factor-α (TNF-α) is elaborated by VSMC in atherosclerosis and following angioplasty. We investigated the role of nuclear factor-κB (NF-κB) in human VSMC migration induced by TNF-α. Adenoviral expression of a mutant form of the inhibitor of NF-κB, IκB-αM, suppressed TNF-α-triggered degradation of cellular IκB-α, inhibited activation of NF-κB, and attenuated TNF-α-induced migration. Further, IκB-αM suppressed TNF-α-stimulated release of interleukin-6 and -8 (IL-6 and IL-8). Neutralization of IL-6 and IL-8 with appropriate antibodies reduced TNF-α-induced VSMC migration. Addition of recombinant IL-6 and IL-8 stimulated migration. Collectively, our data provide initial evidence that TNF-α-mediated VSMC migration requires NF-κB activation and is associated with induction of IL-6 and IL-8 which act in an autocrine manner.

KW - Interleukin-6

KW - Interleukin-8

KW - Migration

KW - Nuclear factor κB

KW - Smooth muscle cell

KW - Tumor necrosis factor-α

UR - http://www.scopus.com/inward/record.url?scp=0035940690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035940690&partnerID=8YFLogxK

U2 - 10.1016/S0014-5793(01)03109-X

DO - 10.1016/S0014-5793(01)03109-X

M3 - Article

VL - 508

SP - 360

EP - 364

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 3

ER -